In conclusion, our study demonstrates that miR-21 inhibits inflammatory responses in the early phase of MI by targeting KBTBD7 and impairing MKK3/6 activation in immune cells, which subsequently prevents excessive scar formation and improves cardiac function. This evidence concerns the gene KBTBD7 and myocardial infarction.